Latest News

Biotech veteran Tony Coles to become CEO of Pfizer neuroscience spinout Cerevel

Tony Coles, remembered by many investors for engineering a $10 billion biotech deal in 2013, will become chief executive of Cerevel, the Pfizer neuroscience spinout to which Bain Capital has pledged up to $350 million in funding, the company announced Monday.

“From my perspective, the area of neuroscience drug discovery is the next frontier for life sciences,” Coles said in an interview. “It’s essentially what HIV AIDS and cancer were two decades ago.”

Read the rest…

Source link

Related posts

It’s the insulin, stupid: How drug pricing’s simplest case study became a top issue for 2020 Democrats


FDA approves first vaginal ring contraceptive that can be used for one year


Medical News Today: Causes and treatments for thinning hair


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World